Based on these findings, we hypothesized that T cells expressing an EGFR-targeting CAR and the CXCR5 receptor will pair with CXCL13 produced by NSCLC tumors, further enhancing the T cell migration and cancer cell killing. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.